This commentary in The Journal of Infectious Diseases authored by members of The Company’s Advisory Team speaks to the efficacy of Grignard Pure against the SARS-CoV-2 virus.
Authors: Manny Goldman, Gedi Mainelis, Toni Choueiri, Ram Ramachandran, Don Schaffner
